An upcoming conference will investigate the latest trends in the medical devices and medtech clinical trials industry with a focus on navigating recent regulatory changes.
The Outsourcing in Clinical Trials: Medical Devices USA 2026 is taking place 2–3 June in Minneapolis, Minnesota, and will start with an examination of macro-level trends in the medical devices industry and the funding landscape for innovation amidst larger macro events in a talk by Charlie Whelan, senior director of Consulting, Medical Devices, GlobalData.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The opening talk will set the tone for speaker presentations planned for the first day, which will cover major themes for medical device trials like lean trial protocols, implementation of decentralised elements, running device-intensive trials in specialty site networks, and digital workflows that take into consideration the participant experience. These will feature speakers from Phillips, Agitated Solutions, Medtronic, the Clayton Sleep Institute, and more.
Later, a fireside chat with Serhii Zatsarynin, chief executive officer, Ovulio, will cover how obtaining consent while protecting participant comprehension can be achieved in a seamless manner.
Artificial intelligence (AI), a key industry theme, will also be discussed by a panel of industry executives who will discuss real-world use cases for technology adoption to provide a holistic view of AI integration activities in the healthcare industry.
The second day of the conference will begin with a discussion with executives from Visura Technologies, Phenomix Sciences, and Freyya, on how industry stakeholders can align on their early research, regulatory, and commercial strategies. The talk will also include suggestions for leadership on how to spur collaboration productively.
Other key themes in the clinical trials industry, like ePROs, clinical trial budget planning, and using the US Food and Drug Administration (FDA)’s real world evidence (RWE) guidance to design fit-for-purpose strategies, will also be covered through presentations by expert speakers.
Since the recent transition to Quality Management System Regulation (QMSR), the FDA regulation that covers medical device manufacturing standards, is a key industry topic, an interactive workshop will provide an opportunity for participants to discuss the successes and challenges associated with the recent changes.
The Outsourcing in Clinical Trials: Medical Devices USA 2026 conference is hosted by Arena International Events Group, a B2B events company owned by GlobalData, the parent company of Clinical Trials Arena and Pharmaceutical Technology. The conference agenda can be found here.
Interested in attending or sponsoring OCT Medical Devices? Complete the form below, and the Arena team will be in touch;
